VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy. (2014)

First Author: Lines JL
Attributed to:  MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2326-6066.CIR-14-0072

PubMed Identifier: 24894088

Publication URI: http://europepmc.org/abstract/MED/24894088

Type: Journal Article/Review

Volume: 2

Parent Publication: Cancer immunology research

Issue: 6

ISSN: 2326-6066